Anti-tumor effects of ATRA were also observed in a study by Ming-Jer Young et al., whereby ATRA downregulated ALDH1 cancer SC (CSC) marker expression, and inhibited tumor formation in ovarian cancer cells [41]. The gene discussed is ALDH1A1; the disease is ovarian carcinoma.